Bio-Rad Laboratories, Inc. (BIO) vs Shoulder Innovations, Inc. (SI)
A side-by-side comparison of Bio-Rad Laboratories, Inc. and Shoulder Innovations, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 6, 2026. Differences are shown without an overall score or investment verdict.
BIO
Bio-Rad Laboratories, Inc.
$342.43HealthcareDelayed quote: Aug 6, 2026, 4:00 PM EDT
SI
Shoulder Innovations, Inc.
$22.43HealthcareDelayed quote: Aug 6, 2026, 4:00 PM EDT
Total return — BIO vs SI
growth of $100 · dividends reinvested · last 1yBIO +26.7%SI +50.2%SI compounded faster
BIO SI
BIO vs SI: by the numbers
- •BIO is the larger company ($9.22B vs $465M market cap).
- •BIO is profitable (8.59% net margin) while SI runs a net loss (-81.78%).
Metrics side by side
Valuation
| Metric | BIO | SI |
|---|---|---|
| P/E ratio | 41.51 | N/A |
| Forward P/E | 37.87 | N/A |
| P/S ratio | 3.55 | 8.66 |
| P/B ratio | 1.28 | 3.51 |
| EV / EBITDA | 25.89 | N/A |
| FCF yield | 3.85% | N/A |
Profitability
| Metric | BIO | SI |
|---|---|---|
| Gross margin | 51.90% | 75.48% |
| Operating margin | 9.08% | -57.48% |
| Net margin | 8.59% | -81.78% |
| ROE | 3.10% | -33.14% |
| ROIC | 2.04% | -14.80% |
Growth (annualized)
| Metric | BIO | SI |
|---|---|---|
| Revenue CAGR (5Y) | 0.29% | N/A |
| EPS CAGR (5Y) | -26.27% | N/A |
| FCF CAGR (5Y) | -9.65% | N/A |
| Total return CAGR (5Y) | -14.60% | N/A |
Frequently asked
- Is BIO or SI more profitable?
- BIO runs the higher net margin — BIO at 8.59% versus SI at -81.78%.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioShoulder Innovations P/E ratioBio-Rad Laboratories dividend yieldShoulder Innovations dividend yieldBio-Rad Laboratories ROEShoulder Innovations ROEBio-Rad Laboratories operating marginShoulder Innovations operating marginBio-Rad Laboratories revenue growthShoulder Innovations revenue growthBio-Rad Laboratories free cash flowShoulder Innovations free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 6, 2026.